Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1811694 | 1.00 | SLC6A2 (0.50) | SLC6A2TAAR1SRRTSHRMAOA | |
| SCHEMBL28914994 | 1.00 | SLC6A2 (0.50) | SLC6A2TAAR1SRRTSHRMAOA | |
| Methacrylic Acid SCHEMBL26100190 | 0.90 | ALPI (0.46) | SLC6A2TAAR1SRRTSHRMAOA | |
| SCHEMBL114063 | 0.90 | SRR (0.55) | SRRTSHRPTGS1 | |
| SCHEMBL113258 | 0.85 | PPARA (0.44) | NPC1RAB9A | |
| SCHEMBL28243883 | 0.85 | PPARA (0.44) | NPC1RAB9A | |
| SCHEMBL2747604 | 0.85 | TAAR1 (0.53) | SLC6A2TAAR1TSHREPHX1SLC7A5 | |
| SCHEMBL2561209 | 0.85 | NPC1 (0.45) | TSHREPHX1NPC1RAB9APTGS1 | |
| SCHEMBL2747602 | 0.85 | TAAR1 (0.53) | SLC6A2TAAR1TSHREPHX1SLC7A5 | |
| SCHEMBL9136582 | 0.85 | PPARG (0.44) | TSHREPHX1NPC1RAB9ACHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320178-A1 | AMPHETAMINE CARBAMATE COMPOUNDS AND METHODS | NOVEN PHARMACEUTICALS, INC. (US) | 2025-10-16 | — | — | US | disclosed |
| US-12365648-B2 | Amphetamine carbamate compounds and methods | NOVEN PHARMACEUTICALS, INC. (US) | 2025-07-22 | — | — | US | disclosed |
| US-20240327337-A1 | AMPHETAMINE CARBAMATE COMPOUNDS AND METHODS | NOVEN PHARMACEUTICALS, INC. (US) | 2024-10-03 | — | — | US | disclosed |
| CN-115477634-B | Analgesic compounds and medical uses thereof | 中国人民解放军军事科学院军事医学研究院 | 2024-02-13 | — | — | CN | disclosed |
| CN-117529665-A | Amphetamine carbamate compounds and methods | 诺芬药品公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-116997330-A | Transdermal amphetamine compositions with low levels of carbamate | 诺芬药品公司 | 2023-11-03 | — | — | CN | disclosed |
| CN-115477634-A | Compound for analgesia and medical application thereof | 中国人民解放军军事科学院军事医学研究院 | 2022-12-16 | — | — | CN | disclosed |
| CN-108472300-A | Cyano thiophene and triazol diazacyclo heptantriene and application thereof | 达纳-法伯癌症研究所股份有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108472299-A | Acetamide thieno triazol diazacyclo heptantriene and application thereof | 达纳-法伯癌症研究所股份有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108472295-A | BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF | 达纳-法伯癌症研究所股份有限公司 | 2018-08-31 | — | — | CN | disclosed |
| CN-108349924-A | Benzenesulfonamido--benzofuran derivatives and application thereof | 纪念斯隆凯特林癌症中心 | 2018-07-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327337-A1 | AMPHETAMINE CARBAMATE COMPOUNDS AND METHODS | CHAT, CES2, NAAA | SLC6A2 98/4885TAAR1 97/4885SRR 3464/4885 |
| US-12365648-B2 | Amphetamine carbamate compounds and methods | CES2, CHAT, ACMSD | SLC6A2 73/4885TAAR1 140/4885SRR 2128/4885 |
| US-20250320178-A1 | AMPHETAMINE CARBAMATE COMPOUNDS AND METHODS | CHAT, CES2, NAAA | SLC6A2 98/4885TAAR1 97/4885SRR 3464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.